The aim of the Signaling, Motility and TEM Assays Core is to provide methodology, experimental evaluation, analysis and interpretation of in vitro assays in order to assess the individual behavior of tumor and stromal cells as well as their interactions. The Core performs assays examining 2D motile cell behavior, 3D invasion, and transendothelial migration. These assays permit a complete evaluation of cell behavior during chemotaxis, invasion and migration across a vascular endothelium, and provide a thorough analysis of the invasive capabilities of a given cell type prior to costly and time-consuming animal studies. Moreover, these in vitro assays support and complement the in vivo studies provided by the Multiphoton Imaging, Invasive and TEM Competent Cell Collection and Analysis Core (Core A). Core B also functions as a programmatic resource for the use of unique protein biosensors and for assays examining invadopod formation, and thus ensures that the application of these technologies is uniform across all of the projects. The assays supported by the Core will permit an acute analysis of the molecular mechanisms used by tumor and stromal cells to promote tumor cell invasion, intravasation and extravasation.

Public Health Relevance

Services provided by Core B are essential for the overall objectives of the Program Project to define the detailed interactions between tumor and stromal cells that support invasion and metastasis. These in vitro assays provide information about cellular behavior and mechanism that is essential for the interpretation of in vivo and intravital imaging studies. The Core also coordinates the use of unique biochemical reagents, biosensors and methodologies developed by individual laboratories for distribution to all of the projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA100324-15
Application #
9369606
Study Section
Special Emphasis Panel (ZCA1-RPRB-C)
Program Officer
Ault, Grace S
Project Start
Project End
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
15
Fiscal Year
2017
Total Cost
$132,005
Indirect Cost
$52,960
Name
Albert Einstein College of Medicine, Inc
Department
Type
Domestic Higher Education
DUNS #
079783367
City
Bronx
State
NY
Country
United States
Zip Code
10461
Liu, Xia; Taftaf, Rokana; Kawaguchi, Madoka et al. (2018) Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov :
Nobre, Ana Rita; Entenberg, David; Wang, Yarong et al. (2018) The Different Routes to Metastasis via Hypoxia-Regulated Programs. Trends Cell Biol 28:941-956
Donnelly, Sara K; Miskolci, Veronika; Garrastegui, Alice M et al. (2018) Characterization of Genetically Encoded FRET Biosensors for Rho-Family GTPases. Methods Mol Biol 1821:87-106
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Norwood Toro, Laura E; Wang, Yarong; Condeelis, John S et al. (2018) Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis. Exp Cell Res 370:273-282
Bresnick, Anne R (2018) S100 proteins as therapeutic targets. Biophys Rev 10:1617-1629
Suyama, Kimita; Yao, Jiahong; Liang, Huizhi et al. (2018) An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary Tumorigenesis. Cancer Res 78:103-114
Pastoriza, Jessica M; Karagiannis, George S; Lin, Juan et al. (2018) Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis 35:613-623
Arwert, Esther N; Harney, Allison S; Entenberg, David et al. (2018) A Unidirectional Transition from Migratory to Perivascular Macrophage Is Required for Tumor Cell Intravasation. Cell Rep 23:1239-1248
Gizzi, Anthony S; Grove, Tyler L; Arnold, Jamie J et al. (2018) A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature 558:610-614

Showing the most recent 10 out of 234 publications